dihexa and semax Peptide: Nasal Spray vs Injectable DIHEXA | Peptide Synthetic |
Description
Short-term treatment with a novel HIF-prolyl hydroxylase inhibitor (GSK1278863) failed to improve measures of performance in subjects with claudication-limited peripheral artery disease
Some side effects typically appear right after a dose increase and fade as the body adapts
investigated in this work
By improving the quality of nightly rest with DSIP, you naturally support your hormonal environment, resulting in a better physique and well-being
